Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project title: NHS National Framework for Transition products commencing 1 October 2024<br/>Offer reference number: CM/TNS/24/5712<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/> <br/>CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) <br/><br/>CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) <br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Accord-UK Ltd | 00079585 | ~£131,150,000 estimated from lot values | 1 lot CM/TNS/24/5712/01 | - |
| Amarox Limited | 10997632 | ~£131,150,000 estimated from lot values | 1 lot CM/TNS/24/5712/01 | - |
| Celix Pharma Ltd. | 12474195 | ~£131,150,000 estimated from lot values | 1 lot CM/TNS/24/5712/01 | - |
| Dr.Reddy's Laboratories (UK) Limited | 01729064 | ~£131,150,000 estimated from lot values | 1 lot CM/TNS/24/5712/01 | - |
| Gilead Sciences Limited | 02543818 | ~£131,150,000 estimated from lot values | 1 lot CM/TNS/24/5712/01 | LOBBYIST Ovid Consulting Ltd (4 quarters) Portland PR Limited (1 quarter) WA Communications Ltd (1 quarter) |
| Glenmark Pharmaceuticals Europe Limited | 05040260 | ~£131,150,000 estimated from lot values | 1 lot CM/TNS/24/5712/01 | - |
| Mercury Pharmaceuticals Limited | 02619880 | ~£131,150,000 estimated from lot values | 1 lot CM/TNS/24/5712/01 | - |
| Seacross Pharmaceuticals Ltd | 07650983 | ~£131,150,000 estimated from lot values | 1 lot CM/TNS/24/5712/01 | - |
| Teva UK Limited | 00302461 | ~£131,960,000 estimated from lot values | 2 lots CM/TNS/24/5712/01 · CM/TNS/24/5712/02 | - |
| Thornton and Ross Ltd | 00185947 | ~£131,150,000 estimated from lot values | 1 lot CM/TNS/24/5712/01 | - |
| Tillomed Laboratories ltd | 02544103 | ~£131,150,000 estimated from lot values | 1 lot CM/TNS/24/5712/01 | - |
| Zentiva Pharma UK Ltd | 02158996 | ~£131,150,000 estimated from lot values | 1 lot CM/TNS/24/5712/01 | - |
This procurement was divided into 2 lots, each awarded separately. 306 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 CM/TNS/24/5712/01 Oct 2024 – May 2026 | £131,150,000 £12 initial term | 25 | Thornton and Ross Ltd Tillomed Laboratories ltd Glenmark Pharmaceuticals Europe Limited Gilead Sciences Limited Amarox Limited Mercury Pharmaceuticals Limited Teva UK Limited Zentiva Pharma UK Ltd Accord-UK Ltd Dr.Reddy's Laboratories (UK) Limited Celix Pharma Ltd. Seacross Pharmaceuticals Ltd | active |
| Lot 2 CM/TNS/24/5712/02 Oct 2024 – Sept 2025 | £810,000 £1 initial term | 6 | Teva UK Limited | active |
Weightings from the notice, applied to every lot.
Government spending data: These suppliers have received £260,400,238 in 954 payments (over £25k) from Department of Health and Social Care, Manchester University NHS Foundation Trust, The Christie NHS Foundation Trust, NHS England, Plymouth Hospitals NHS Trust and 8 more public bodies (2010-04-28 to 2026-03-31).
Published by the buyer on this notice. Check the original notice — details change and are not updated here.